Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOvoca Bio Regulatory News (OVB)

  • There is currently no data for OVB

AIM Listing Commences

29 Jun 2005 10:23

Ovoca Resources PLC29 June 2005 NEWS RELEASE June 29, 2005 Ovoca Resource plc ('Ovoca' or the 'Company') AIM Listing Commences Thursday 30th June 2005 and Initial Phase 2 drilling results Ovoca Resources plc (OVX Dublin and OVG London) is pleased to announce itslisting on the Alternate Investment Market of the London Stock Exchange withtrading to commence on Thursday 30th June 2005. The company is also pleased to announce the preliminary results of the first twodiamond drillholes from the current Phase 2 exploration programme. The drillingwas conducted on the South Leshaya prospect, which is the northern extension ofthe previously drilled Oleninskoye prospect, situated within Ovoca's 152 squarekilometre Kolmozero-Voronya licence in the Kola Peninsula of Northwest Russia. South Leshaya is in addition to the eight previously defined gold bearingstructures within the licence area. In addition to gold, the area isprospective for platinum group metals (pgm), which have been found extensive inthe adjacent Oleninskoye prospect. Assay results from two of the explorationdrill holes have been received. High grade gold mineralisation has beenintersected in a silicified amphibolite over two intersections within boreholeBF-041 with maximum grade of 80.0 grammes per tonne. Borehole BF-044intersected 211 grammes per tonne (6.78 ounces per tonne) over a 2 metrethickness. Two check assays were run on the samples from these threeintersections to confirm the results. Preliminary Results South Leshaya Phase 2 Diamond Drill Hole Assays Hole From To Intersection Gold Number (metres) (grammes/tonne) BF-041 7.0 8.5 1.5 12.3 86,8 88,5 1.7 80.3 BF-044 5,0 7,0 2.0 211.0 Dr Barrie Oakes, CEO of Ovoca Resources, stated ... "The results of 80 grammesper tonne over 1.7 metres and 211 grammes per tonne over 2 metres, following the83 grammes per tonne over 2.8 metres in Phase 1, are very consistent andencouraging. These are exceptional results and we eagerly await more from ourongoing Phase 2 drilling programme. We believe that these results confirm ourconviction that there is widespread high grade gold mineralisation throughoutthe 152 square kilometre licence area. We plan to accelerate the work ratefollowing our recent fundraising." Contacts Barrie Oakes +44 (0)7951139266 Roger Turner +44 (0)7739092813 John O'Connor +353 (0)1491 2944 Richard O'Shea +353 (0)872560 397 Fergal Meegan (Davy Corporate Finance) +353 (0)1 679 6363 This announcement has been issued through the Companies Announcement Service of the Irish Stock Exchange. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
5th Feb 20267:00 amRNSChange of Name
28th Jan 20268:00 amRNSReadmission - Ovoca Bio PLC
28th Jan 20267:00 amRNSFirst Day of Dealings on AIM
27th Jan 20262:32 pmRNSResult of Meeting
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20258:00 amRNSSchedule One - Ovoca Bio Plc
31st Dec 20257:00 amRNSNotice of AGM
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSPublication of Admission Document
31st Dec 20257:00 amRNSNotice of AGM
13th Nov 20257:00 amRNSChange of Broker
30th Sep 20251:09 pmRNSReplacement Half Year Report
30th Sep 20257:00 amRNSHalf-year Report
26th Jun 20257:00 amRNSPublication of 2024 Annual Report
5th Jun 20257:00 amRNSDelisting from Euronext Growth Exchange
7th May 20257:30 amRNSSuspension - Ovoca Bio plc
7th May 20257:00 amRNSProposed Acquisition, Disposal & Reverse Takeover
3rd Mar 20252:00 pmRNSManagement Changes
18th Dec 20246:00 pmRNSResult of AGM
18th Nov 20247:00 amRNSNotice of AGM
11th Oct 20245:30 pmRNSHolding(s) in Company
9th Oct 20245:45 pmRNSSale of Treasury Shares
25th Sep 20247:00 amRNSHalf-year Report
2nd Sep 20242:30 pmRNSConsultancy Agreement
15th Jul 20247:00 amRNSDirector/PDMR Shareholding
15th Jul 20247:00 amRNSDirectorate Change
28th Jun 20247:00 amRNSAnnual Financial Report
23rd Jan 20247:00 amRNSHolding(s) in Company
1st Dec 202312:00 pmRNSResult of AGM
7th Nov 20239:15 amRNSNotice of AGM
28th Sep 20237:00 amRNSInterim Results
31st Aug 20237:00 amRNSSummary Results of Phase II Study for Orenetide
30th Jun 20237:00 amRNSAnnual Financial Report
12th Jun 20237:00 amRNSUpdate on Completion Timelines for Phase II Study
16th Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20232:05 pmRNSSecond Price Monitoring Extn
16th Mar 20232:00 pmRNSPrice Monitoring Extension
16th Mar 20239:05 amRNSSecond Price Monitoring Extn
16th Mar 20239:00 amRNSPrice Monitoring Extension
8th Mar 20237:00 amRNSDisposal of Russian Assets
14th Feb 20234:41 pmRNSSecond Price Monitoring Extn
14th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20232:05 pmRNSSecond Price Monitoring Extn
14th Feb 20232:00 pmRNSPrice Monitoring Extension
13th Feb 20239:00 amRNSPrice Monitoring Extension
13th Jan 202311:05 amRNSSecond Price Monitoring Extn
13th Jan 202311:00 amRNSPrice Monitoring Extension
28th Oct 20227:00 amRNSResult of AGM
6th Oct 20222:30 pmRNSNotice of AGM
30th Sep 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.